Surprisingly, there was no statistically significant difference in weight between tumors grown from CD49b-neg and CD49b-pos cells, although there was greater variability in tumor size in the CD49b-neg group (Fig. 7A). The gene discussed is ITGA2; the disease is neoplasm.